Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713748 | SCV000844377 | uncertain significance | not provided | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312256 | SCV000846311 | benign | Inborn genetic diseases | 2017-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000713748 | SCV001001778 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713748 | SCV001500812 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | SZT2: BP4, BS2 |
Baylor Genetics | RCV001335728 | SCV001528956 | uncertain significance | Developmental and epileptic encephalopathy, 18 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000713748 | SCV001792800 | likely benign | not provided | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000713748 | SCV001929953 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000713748 | SCV001976213 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003918152 | SCV004733647 | likely benign | SZT2-related disorder | 2020-07-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |